401 related articles for article (PubMed ID: 17445570)
1. Histocompatibility testing for highly sensitized transplant candidates.
Saidman SL
Transplant Proc; 2007 Apr; 39(3):673-5. PubMed ID: 17445570
[TBL] [Abstract][Full Text] [Related]
2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
3. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
[TBL] [Abstract][Full Text] [Related]
4. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
[TBL] [Abstract][Full Text] [Related]
5. The changing role of antibody testing in transplantation.
Leffell MS; Montgomery RA; Zachary AA
Clin Transpl; 2005; ():259-71. PubMed ID: 17424745
[TBL] [Abstract][Full Text] [Related]
6. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
[TBL] [Abstract][Full Text] [Related]
7. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
8. [Histocompatibility tests in a transplantation program].
de-Leo-Cervantes C
Rev Invest Clin; 2005; 57(2):142-6. PubMed ID: 16524052
[TBL] [Abstract][Full Text] [Related]
9. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
Aubert V; Venetz JP; Pantaleo G; Pascual M
Hum Immunol; 2009 Aug; 70(8):580-3. PubMed ID: 19375474
[TBL] [Abstract][Full Text] [Related]
10. Hidden perils in a highly sensitized kidney transplant recipient.
Ford S; Summers S; Cantwell L; Mulley W
Nephrology (Carlton); 2012 Apr; 17 Suppl 1():9-11. PubMed ID: 22497647
[TBL] [Abstract][Full Text] [Related]
11. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
Delgado JC; Eckels DD
Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Panel Reactive Antibodies in Renal Transplant Recipients Detected by Luminex: A Single-Center Experience.
İnal A; Özçelik Ü; Ogan Uyanık E; Külah E; Demirağ A
Exp Clin Transplant; 2016 Aug; 14(4):401-4. PubMed ID: 26517205
[TBL] [Abstract][Full Text] [Related]
13. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival.
Vlad G; Ho EK; Vasilescu ER; Colovai AI; Stokes MB; Markowitz GS; D'Agati VD; Cohen DJ; Ratner LE; Suciu-Foca N
Hum Immunol; 2009 Aug; 70(8):589-94. PubMed ID: 19375470
[TBL] [Abstract][Full Text] [Related]
14. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.
Tyan DB; Li VA; Czer L; Trento A; Jordan SC
Transplantation; 1994 Feb; 57(4):553-62. PubMed ID: 8116041
[TBL] [Abstract][Full Text] [Related]
15. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
[TBL] [Abstract][Full Text] [Related]
16. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.
Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE
J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925
[TBL] [Abstract][Full Text] [Related]
17. Clinical cytometry and progress in HLA antibody detection.
Bray RA; Tarsitani C; Gebel HM; Lee JH
Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
[TBL] [Abstract][Full Text] [Related]
18. Current methodologies for detecting sensitization to HLA antigens.
Cecka JM
Curr Opin Organ Transplant; 2011 Aug; 16(4):398-403. PubMed ID: 21666477
[TBL] [Abstract][Full Text] [Related]
19. Solid phase assays for HLA antibody detection in clinical transplantation.
Tait BD
Curr Opin Immunol; 2009 Oct; 21(5):573-7. PubMed ID: 19765965
[TBL] [Abstract][Full Text] [Related]
20. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
